Login Register Cart 0
Generic placeholder image

Current Reviews in Clinical and Experimental Pharmacology

Editor-in-Chief

ISSN (Print): 2772-4328
ISSN (Online): 2772-4336

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Research Article

Formulation and Evaluation of Polyherbal Cream and Lotion for the Treatment of Psoriasis-Induced Secondary Infections

Author(s): Priyanka Joshi, Sushil Joshi*, Urvashi Rajani, Ruchi B. Semwal and Deepak K. Semwal*

Volume 16, Issue 1, 2021

Published on: 17 October, 2019

Page: [79 - 96] Pages: 18

DOI: 10.2174/1574884714666191017111218

Abstract

Background: Psoriasis is one of the most common skin diseases in humans and affects a major population worldwide. The aim of the present study is to evaluate the efficacy of selected polyherbal formulations against psoriasis-induced secondary infections.

Aim: Psoriasis is one of the most common skin diseases in humans and affects a major population worldwide. The aim of the present study is to evaluate the efficacy of selected polyherbal formulations against psoriasis-induced secondary infections.

Methods: Samples were collected from the scalp, behind the ears, chest and back of the patients. The microscopic examination of fungal and bacterial growth was carried out with lactophenol cotton blue stain and gram stain, respectively. Volatile constituents of essential oils were identified by GC-MS analysis, in order to investigate the relation between chemical composition and biological activity. Nutrient agar media was used for antibacterial activity whereas Sabourauds dextrose agar media was used for antifungal activity.

Results: A total of 24 isolates were obtained from 2 patients of scalp psoriasis. Anti-oxidant activity of the samples was determined using DPPH radical scavenging method. In the present study, EOs showed a good antifungal action against Malassezia pachydermatis and other microbial strains. The GC-MS analysis revealed the presence of eugenol, linalool, citral, neral, limonene, terpenes, eucalyptol and thymol in the essential oils. The formulated retention lotion 1 (L4), 2 (L5), 3 (L6) and Cream 1 (C1) showed DPPH radical scavenging activity by 23.52%, 24.48%, 28% and 5.08%, respectively.

Conclusion: The present study concluded that most of the formulated lotions and creams showed good antimicrobial activity and may be applied topically against scalp psoriasis.

Keywords: Malassezia pachydermatis, essential oil, eugenol, Candida spp. scalp psoriasis, amplification.

« Previous
Graphical Abstract

[1]
Vellapan R, Venu S, Ramasamy S, Chellapan L. Current scenario in clinical trends of psoriasis in tertiary care hospital. Int J Res Dermatol 2019; 5(3): 1-5.
[http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20192068]
[2]
Korotky N, Peslyak M. Psoriasis as a consequence of incorporation of beta-streptococci into the microbiocenosis of highly permeable intestines (a pathogenic concept) arXiv preprint arXiv:11095012
[3]
Bateson-Koch C. Allergies disease in disguise: How to heal your allergic condition permanently and naturally. Book Publishing Company 2002.
[4]
Lowe NJ, Ed. Psoriasis: A Patient’s Guide. CRC Press 1998.
[5]
Carlo J, Chinea N, Rivera C. Pharmaceutical composition US Patent Application No 10109,453, 2002.
[6]
Menter MA, Weinstein GD. An overview of psoriasis. 4th ed. Moderate to Severe Psoriasis 2014; pp. 1-22.
[7]
Ramoz N, Rueda LA, Bouadjar B, Favre M, Orth G. A susceptibility locus for Epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J Invest Dermatol 1999; 112(3): 259-63.
[http://dx.doi.org/10.1046/j.1523-1747.1999.00536.x] [PMID: 10084299]
[8]
Asahina A, Akazaki S, Nakagawa H, et al. Specific nucleotide sequence of HLA-C is strongly associated with psoriasis vulgaris. J Invest Dermatol 1991; 97(2): 254-8.
[http://dx.doi.org/10.1111/1523-1747.ep12480361] [PMID: 2071937]
[9]
Fernandez-Vina MA, Young M, Lory D, Menter A, Bowcockt A. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 1 7q. Nature 1986; 320: 552.
[10]
Matthews D, Fry L, Powles A, et al. Evidence that a locus for familial psoriasis maps to chromosome 4q. Nat Genet 1996; 14(2): 231-3.
[http://dx.doi.org/10.1038/ng1096-231] [PMID: 8841203]
[11]
Hardas BD, Zhao X, Zhang J, Longqing X, Stoll S, Elder JT. Assignment of psoriasin to human chromosomal band 1q21: coordinate overexpression of clustered genes in psoriasis. J Invest Dermatol 1996; 106(4): 753-8.
[http://dx.doi.org/10.1111/1523-1747.ep12345807] [PMID: 8618016]
[12]
Trembath RC, Clough RL, Rosbotham JL, et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997; 6(5): 813-20.
[http://dx.doi.org/10.1093/hmg/6.5.813] [PMID: 9158158]
[13]
Höhler T, Kruger A, Schneider PM, et al. A TNF-α promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 1997; 109(4): 562-5.
[http://dx.doi.org/10.1111/1523-1747.ep12337469] [PMID: 9326391]
[14]
Jenisch S, Henseler T, Nair RP, et al. Linkage analysis of Human Leukocyte Antigen (HLA) markers in familial psoriasis: Strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet 1998; 63(1): 191-9.
[http://dx.doi.org/10.1086/301899] [PMID: 9634500]
[15]
Capon F, Munro M, Barker J, Trembath R. Searching for the major histocompatibility complex psoriasis susceptibility gene. J Invest Dermatol 2002; 118(5): 745-51.
[http://dx.doi.org/10.1046/j.1523-1747.2002.01749.x] [PMID: 11982750]
[16]
Nair RP, Henseler T, Jenisch S, et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 1997; 6(8): 1349-56.
[http://dx.doi.org/10.1093/hmg/6.8.1349] [PMID: 9259283]
[17]
Asumalahti K, Laitinen T, et al. Psoriasis suscep-tibility locus on 18p revealed by genome scan in Finnish families not associated with PSORS1. J Invest Dermatol 2003; 121(4): 735-40.
[http://dx.doi.org/10.1093/hmg/6.5.813] [PMID: 9158158]
[18]
International Psoriasis Genetics Consortium. The International Psoriasis Genetics Study: Assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs. Am J Hum Genet 2003; 73(2): 430-7.
[http://dx.doi.org/10.1086/377159] [PMID: 12851855]
[19]
Al Robaee AA. Molecular genetics of Psoriasis (Principles, technology, gene location, genetic polymorphism and gene expression). Int J Health Sci (Qassim) 2010; 4(2): 103-27.
[PMID: 21475550]
[20]
Martin MP, Nelson G, Lee JH, et al. Cutting edge: susceptibility to psoriatic arthritis: Influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 2002; 169(6): 2818-22.
[http://dx.doi.org/10.4049/jimmunol.169.6.2818] [PMID: 12218090]
[21]
Helms C, Cao L, Krueger JG, et al. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet 2003; 35(4): 349-56.
[http://dx.doi.org/10.1038/ng1268] [PMID: 14608357]
[22]
Nestle FO, Conrad C. Mechanisms of psoriasis. Drug Discov Today Dis Mech 2004; 1(3): 315-9.
[http://dx.doi.org/10.1016/j.ddmec.2004.11.005]
[23]
Diani M, Altomare G, Reali E. T cell responses in psoriasis and psoriatic arthritis. Autoimmun Rev 2015; 14(4): 286-92.
[http://dx.doi.org/10.1016/j.autrev.2014.11.012] [PMID: 25445403]
[24]
Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007; 445(7130): 866-73.
[http://dx.doi.org/10.1038/nature05663] [PMID: 17314973]
[25]
Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008; 58(5): 826-50.
[http://dx.doi.org/10.1016/j.jaad.2008.02.039] [PMID: 18423260]
[26]
Nickoloff BJ, Nestle FO. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 2004; 113(12): 1664-75.
[http://dx.doi.org/10.1172/JCI200422147] [PMID: 15199399]
[27]
McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 2006; 27(1): 17-23.
[http://dx.doi.org/10.1016/j.it.2005.10.003] [PMID: 16290228]
[28]
Guttman-Yassky E, Krueger JG. Psoriasis: Evolution of pathogenic concepts and new therapies through phases of translational research. Br J Dermatol 2007; 157(6): 1103-15.
[http://dx.doi.org/10.1111/j.1365-2133.2007.08135.x] [PMID: 17714560]
[29]
Di Meglio P, Perera GK, Nestle FO. The multitasking organ: Recent insights into skin immune function. Immunity 2011; 35(6): 857-69.
[http://dx.doi.org/10.1016/j.immuni.2011.12.003] [PMID: 22195743]
[30]
Lowes MA, Russell CB, Martin DA, Towne JE, Krueger JG. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol 2013; 34(4): 174-81.
[http://dx.doi.org/10.1016/j.it.2012.11.005] [PMID: 23291100]
[31]
Di Meglio P, Nestle FO. Immunopathogenesis of Psoriasis.Clinical and Basic Immunodermatology. Springer International Publishing 2017; pp. 373-95.
[http://dx.doi.org/10.1007/978-3-319-29785-9_21]
[32]
Skov L, Baadsgaard O. Bacterial superantigens and inflammatory skin diseases. Clin Exp Dermatol 2000; 25(1): 57-61.
[http://dx.doi.org/10.1046/j.1365-2230.2000.00575.x] [PMID: 10671976]
[33]
Weisenseel P, Prinz JC. Incidental detection of S. pyogenes-DNA in psoriatic skin by PCR. Arch Dermatol Res 2005; 296(12): 573-6.
[http://dx.doi.org/10.1007/s00403-005-0559-7] [PMID: 15856267]
[34]
Tomi NS, Kränke B, Aberer E. Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects. J Am Acad Dermatol 2005; 53(1): 67-72.
[http://dx.doi.org/10.1016/j.jaad.2005.02.034] [PMID: 15965423]
[35]
Talanin NY, Shelley WB, Raeder R, Shelley ED, Boyle MD. Detection of streptococcal class I M protein in psoriasis by confocal immunofluorescent microscopy. Acta Derm Venereol 1997; 77(3): 175-80.
[PMID: 9188864]
[36]
Hollox EJ, Huffmeier U, Zeeuwen PL, et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 2008; 40(1): 23-5.
[http://dx.doi.org/10.1038/ng.2007.48] [PMID: 18059266]
[37]
Gao Z, Tseng CH, Strober BE, Pei Z, Blaser MJ. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS One 2008; 3(7)e2719
[http://dx.doi.org/10.1371/journal.pone.0002719] [PMID: 18648509]
[38]
Paulino LC, Tseng CH, Strober BE, Blaser MJ. Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. J Clin Microbiol 2006; 44(8): 2933-41.
[http://dx.doi.org/10.1128/JCM.00785-06] [PMID: 16891514]
[39]
Paulino LC, Tseng CH, Blaser MJ. Analysis of Malassezia microbiota in healthy superficial human skin and in psoriatic lesions by multiplex real-time PCR. FEMS Yeast Res 2008; 8(3): 460-71.
[http://dx.doi.org/10.1111/j.1567-1364.2008.00359.x] [PMID: 18294199]
[40]
Fry L, Baker BS, Powles AV, Fahlen A, Engstrand L. Is chronic plaque psoriasis triggered by microbiota in the skin? Br J Dermatol 2013; 169(1): 47-52.
[http://dx.doi.org/10.1111/bjd.12322] [PMID: 23521130]
[41]
Amaya M, Tajima M, Okubo Y, Sugita T, Nishikawa A, Tsuboi R. Molecular analysis of Malassezia microflora in the lesional skin of psoriasis patients. J Dermatol 2007; 34(9): 619-24.
[http://dx.doi.org/10.1111/j.1346-8138.2007.00343.x] [PMID: 17727364]
[42]
Takemoto A, Cho O, Morohoshi Y, Sugita T, Muto M. Molecular characterization of the skin fungal microbiome in patients with psoriasis. J Dermatol 2015; 42(2): 166-70.
[http://dx.doi.org/10.1111/1346-8138.12739] [PMID: 25510344]
[43]
Taheri Sarvtin M, Shokohi T, Hajheydari Z, Yazdani J, Hedayati MT. Evaluation of candidal colonization and specific humoral responses against Candida albicans in patients with psoriasis. Int J Dermatol 2014; 53(12): e555-60.
[http://dx.doi.org/10.1111/ijd.12562] [PMID: 25427068]
[44]
Armstrong AW, Bukhalo M, Blauvelt A. A Clinician’s guide to the diagnosis and treatment of candidiasis in patients with psoriasis. Am J Clin Dermatol 2016; 17(4): 329-36.
[http://dx.doi.org/10.1007/s40257-016-0206-4] [PMID: 27435194]
[45]
Chen Y, Lyga J. Brain-skin connection: Stress, inflammation and skin aging. Inflamm Allergy Drug Targets 2014; 13(3): 177-90.
[http://dx.doi.org/10.2174/1871528113666140522104422] [PMID: 24853682]
[46]
Katta R, Desai SP. Diet and dermatology: The role of dietary intervention in skin disease. J Clin Aesthet Dermatol 2014; 7(7): 46-51.
[PMID: 25053983]
[47]
Chopra A, Doiphode VV. Ayurvedic medicine. Core concept, therapeutic principles, and current relevance. Med Clin North Am 2002; 86(1): 75-89.vii.
[http://dx.doi.org/10.1016/S0025-7125(03)00073-7] [PMID: 11795092]
[48]
Papadopoulos L, Walker C. Understanding skin problems: acne, eczema, psoriasis and related conditions. John Wiley & Sons 2003.
[49]
Soares RC, Camargo-Penna PH, de Moraes VC, et al. Dysbiotic bacterial and fungal communities not restricted to clinically affected skin sites in dandruff. Front Cell Infect Microbiol 2016; 6: 157.
[http://dx.doi.org/10.3389/fcimb.2016.00157] [PMID: 27909689]
[50]
Sakthivel S, Angaleswari C, Mahalingam PU. Isolation and identification of bacteria responsible for flacherie in silkworms. J Microbiol Biotechn Res 2017; 2(6): 913-5.
[51]
O’hara CM. Manual and automated instrumentation for identification of Enterobacteriaceae and other aerobic gram-negative bacilli. Clin Microbiol Rev 2005; 18(1): 147-62.
[http://dx.doi.org/10.1128/CMR.18.1.147-162.2005] [PMID: 15653824]
[52]
Jyothiprabha V, Venkatachalam P. Preliminary phytochemical screening of different solvent extracts of selected lndian spices. Int J Curr Microbiol Appl Sci 2016; 5(2): 116-22.
[http://dx.doi.org/10.20546/ijcmas.2016.502.013]
[53]
Kulisic T, Radonic A, Katalinic V, Milos M. Use of different methods for testing antioxidative activity of oregano essential oil. Food Chem 2004; 85(4): 633-40.
[http://dx.doi.org/10.1016/j.foodchem.2003.07.024]
[54]
Durai MV, Balamuniappan G, Anandalakshmi R, Geetha S, Senthil Kumar N. Qualitative and quantitative analysis of phytochemicalsin crude extract of big - Leaf mahogany (Swietenia macrophylla King.). Int J Herb Med 2016; 4(6): 88-91.
[55]
Santhi K, Sengottuvel R. Qualitative and quantitative phytochemical analysis of Moringa concanensis Nimmo. Int J Curr Microbiol Appl Sci 2016; 5(1): 633-40.
[http://dx.doi.org/10.20546/ijcmas.2016.501.064]
[56]
Teixeira B, Marques A, Ramos C, et al. Chemical composition and antibacterial and antioxidant properties of commercial essential oils. Ind Crops Prod 2013; 43: 587-95.
[http://dx.doi.org/10.1016/j.indcrop.2012.07.069]
[57]
Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical management. J Clin Aesthet Dermatol 2011; 4(5): 32-8.
[PMID: 21607192]

Rights & Permissions Print Cite
Article Metrics
37
2
© 2024 Bentham Science Publishers | Privacy Policy